Literature DB >> 22362307

Two molecular weight species of thrombospondin-2 are present in bone and differentially modulated in fractured and nonfractured tibiae in a murine model of bone healing.

Andrea I Alford1, Anita B Reddy, Steven A Goldstein, Prithvi Murthy, Riyad Tayim, Gorav Sharma.   

Abstract

We report two immuoreactive species of thrombospondin-2 (TSP2), sized approximately 200 and 125 kDa, in the long bones of growing, but not skeletally mature, mice. In vitro osteoblasts secrete a 200-kDa species into the culture medium as early as day 3, and it appears in the cell-matrix layer by day 7. A 125-kDa species appears in the cell-matrix layer in parallel with mineralization; it is not detected in cell-conditioned medium. Unilateral tibial fracture induced a time-dependent upregulation of the 200-kDa species at the site of trauma. By contrast, relative levels of the 125-kDa species at the fracture site were lower than in bones from naive control animals. In the contralateral untouched control tibia, the 200-kDa species was rapidly and substantially reduced compared to bone harvested from naive control mice. Levels of the 125-kDa species in the untouched tibia declined gradually with time postfracture. TSP2 gene expression in uninjured control bone decreased modestly by 21 days postfracture. On the day of fracture, the osteoblast differentiation potential of MSCs harvested from uninjured bones decreased compared to those harvested from naive control animals. The presence of two isoforms suggests that TSP2 may undergo posttranscriptional or posttranslational processing in skeletal tissue. Our data also suggest that, in the context of trauma, the two TSP2 isforms are differentially modulated at injured and noninjured skeletal sites in an animal undergoing fracture healing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362307      PMCID: PMC3374957          DOI: 10.1007/s00223-012-9580-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

Review 1.  Circulating osteogenic cells: implications for injury, repair, and regeneration.

Authors:  Robert J Pignolo; Moustapha Kassem
Journal:  J Bone Miner Res       Date:  2011-05-02       Impact factor: 6.741

2.  Regenerating marrow induces systemic increase in osteo- and chondrogenesis.

Authors:  D Gazit; M Karmish; L Holzman; I Bab
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

3.  The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue.

Authors:  S Amsel; A Maniatis; M Tavassoli; W H Crosby
Journal:  Anat Rec       Date:  1969-05

4.  Removal of tibial marrow induces increased formation of bone and cartilage in rat mandibular condyle.

Authors:  I Bab; D Gazit; A Massarawa; J Sela
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

Review 5.  Polypeptide factors regulating osteogenesis and bone marrow repair.

Authors:  I A Bab; T A Einhorn
Journal:  J Cell Biochem       Date:  1994-07       Impact factor: 4.429

6.  The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation.

Authors:  Kurt D Hankenson; Paul Bornstein
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

7.  A standardized experimental fracture in the mouse tibia.

Authors:  A Hiltunen; E Vuorio; H T Aro
Journal:  J Orthop Res       Date:  1993-03       Impact factor: 3.494

8.  Inhibition of angiogenesis by thrombospondin-2.

Authors:  O V Volpert; S S Tolsma; S Pellerin; J J Feige; H Chen; D F Mosher; N Bouck
Journal:  Biochem Biophys Res Commun       Date:  1995-12-05       Impact factor: 3.575

9.  In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.

Authors:  Valérie Geoffroy; Caroline Marty-Morieux; Nathalie Le Goupil; Phillippe Clement-Lacroix; Catherine Terraz; Monique Frain; Sophie Roux; Jérome Rossert; Marie Christine de Vernejoul
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741

10.  Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity.

Authors:  I Bab; D Gazit; M Chorev; A Muhlrad; A Shteyer; Z Greenberg; M Namdar; A Kahn
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  5 in total

1.  Thrombospondin-2 deficiency in growing mice alters bone collagen ultrastructure and leads to a brittle bone phenotype.

Authors:  Eugene Manley; Joseph E Perosky; Basma M Khoury; Anita B Reddy; Kenneth M Kozloff; Andrea I Alford
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Compound deletion of thrombospondin-1 and -2 results in a skeletal phenotype not predicted by the single gene knockouts.

Authors:  Andrea I Alford; Chris Stephan; Kenneth M Kozloff; Kurt D Hankenson
Journal:  Bone       Date:  2021-08-20       Impact factor: 4.398

3.  Thrombospondin-2 facilitates assembly of a type-I collagen-rich matrix in marrow stromal cells undergoing osteoblastic differentiation.

Authors:  Andrea I Alford; Andrew Z Golicz; Amber Lee Cathey; Anita B Reddy
Journal:  Connect Tissue Res       Date:  2013-07-19       Impact factor: 3.417

4.  Evaluation of global gene expression in regenerate tissues during Masquelet treatment.

Authors:  Nishant Gohel; Rafael Senos; Steven A Goldstein; Kurt D Hankenson; Mark E Hake; Andrea I Alford
Journal:  J Orthop Res       Date:  2020-04-06       Impact factor: 3.494

5.  Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism.

Authors:  Jacqueline Nguyen; Simon Y Tang; Daniel Nguyen; Tamara Alliston
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.